Cf. Nelson et al., THE EFFICACY OF SPINAL MANIPULATION, AMITRIPTYLINE AND THE COMBINATION OF BOTH THERAPIES FOR THE PROPHYLAXIS OF MIGRAINE HEADACHE, Journal of manipulative and physiological therapeutics, 21(8), 1998, pp. 511-519
Background: Migraine headache affects approximately 11 million adults
in the United States. Spinal manipulation is a common alternative ther
apy for headaches, but its efficacy compared with standard medical the
rapies is unknown. Objective: To measure the relative efficacy of amit
riptyline, spinal manipulation and the combination of both therapies f
or the prophylaxis of migraine headache. Design: A prospective, random
ized, parallel-group comparison. After a 4-wk baseline period, patient
s were randomly assigned to 8 wk of treatment, after which there was a
4-wk follow-up period. Setting: Chiropractic college outpatient clini
c. Participants: A total of 218 patients with the diagnosis of migrain
e headache.Interventions: An 8-wk course of therapy with spinal manipu
lation, amitriptyline or a combination of the two treatments. Main Out
come Measures: A headache index score derived from a daily headache pa
in diary during the last 4 wk of treatment and during the 4-wk follow-
up period. Results: Clinically important improvement was observed in b
oth primary and secondary outcomes in all three study groups over time
. The reduction in headache index scores during treatment compared wit
h baseline was 49% for amitriptyline, 40% for spinal manipulation and
41% for the combined group; p = .66. During the posttreatment follow-u
p period the reduction from baseline was 24% for amitriptyline, 42% fo
r spinal manipulation and 25% for the combined group; p = .05. Conclus
ion: There was no advantage to combining amitriptyline and spinal mani
pulation for the treatment of migraine headache. Spinal manipulation s
eemed to be as effective as a well-established and efficacious treatme
nt (amitriptyline), and on the basis of a benign side effects profile,
it should be considered a treatment option for patients with frequent
migraine headaches.